-
-
-
-
-
-
-
Applied Therapeutics Reports Second Quarter 2025 Financial Results
-
-
-
-
-
-
-
Applied Therapeutics Reports Fourth Quarter and Year-end 2024 Financial Results
-
-
-
-
-
-
-
Applied Therapeutics Reports Third Quarter 2024 Financial Results
-
-
-
-
-
-
-
Applied Therapeutics (APLT) Appoints Dale Hooks as Chief Commercial Officer
-
-
-
-
-
-
-
Applied Therapeutics (APLT) Announces FDA Acceptance and Priority Review of New Drug Application for Govorestat for the Treatment of Classic Galactosemia
-
-
-
-
-
-
-
Applied Therapeutics Announces Topline Results from the ARISE-HF Phase 3 Study of AT-001 in Diabetic Cardiomyopathy
-
-
-
-
-
-
-
Applied Therapeutics Reports Second Quarter 2023 Financial Results
-
1,168,522 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

